Purple Biotech (PPBT) Financials

$1.44

$-0.11 (-6.80%)

As on 18-Sep-2026 16:00EDT

Market cap

$2 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

0.2

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	--	--	--	0.20	-0.91	-0.32
Cost of Revenue	0.18	0.20	0.19	0.20	0.00	0.00
Gross Profit	-0.18	-0.20	-0.19	0.00	0.00	0.00
Operating Expenses	28.36	27.46	11.01	22.27	22.60	17.93
Operating Profit (EBIT)	-28.36	-27.46	-11.01	-22.27	-22.60	-17.93
Other Income	--	--	--	--	--	--
Profit before Tax	-24.60	-26.49	-7.28	-19.98	-21.76	-17.83
Provision for Tax	--	--	--	-0.10	0.88	0.64
Profit after Tax (Net Income)	-24.49	-26.39	-7.24	-19.88	-21.67	-18.38
Minority Interest	0.10	0.11	0.04	0.10	0.09	0.08
Consolidated Profit	--	--	--	--	-21.67	-18.38

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	12.27	9.71	32.86	34.21	46.91	64.83
Minority Interest	0.10	--	--	--	--	--
Non-Current Liabilities	0.17	0.16	0.14	0.30	0.47	0.84
Current Liabilities	1.78	7.75	3.99	9.70	7.06	4.25
Total Liabilities	15.95	17.57	37.04	44.30	54.62	70.20

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	7.58	7.71	28.13	28.51	21.37	21.73
Current Assets	6.59	9.87	8.91	15.79	33.26	48.47
Total Assets	15.95	17.57	37.04	44.30	54.62	70.20
Total Debt*	0.13	0.24	0.18	0.35	0.52	0.75
Net Current Assets	4.81	2.11	4.92	8.61	26.20	44.22

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-5.54	-14.37	-19.93	-16.74	-15.25
Cash Flow from Investing Activities	--	0.45	0.51	13.88	19.91	13.41
Cash from Financing Activities	--	6.41	6.77	5.45	1.11	1.51
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-2.23	-2.22	-3.53	-15.42	-23.56	-20.96
Cash EPS ($)	-47.64	-2.20	-3.44	-15.26	-23.35	-20.70
Adjusted Book Value ($)	12.00	0.82	16.02	26.53	51.02	73.92
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-0.46	-7.00	-15.45	-18.20	-17.39
Free Cash Flow per Share ($)	--	-0.47	-7.00	-15.45	-18.45	-17.52

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-122.72	-21.42	-48.50	-38.35	-25.21
ROE (%)	-221.89	-123.95	-21.59	-49.02	-38.78	-25.50
ROA (%)	-93.28	-96.63	-17.80	-40.19	-34.72	-23.88
EBIT Margin (%)	--	--	--	-10,173.95	2,383.85	5,545.94
Net Margin (%)	--	--	--	-10,153.01	2,381.10	5,745.00
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	--	--	-1.00	1.22	-1.84	-1.32
EBIT Growth (%)	-845.89	-265.47	63.67	8.17	-22.23	-33.12
Net Profit Growth (%)	-840.29	-264.45	63.58	8.25	-17.86	34.80
EPS Growth (%)	-93.88	0.37	0.77	0.35	-0.12	0.37
Book Value Growth (%)	-90.34	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-0.30	-1.33	-0.05	-0.06	-0.19
Price / Book Value	0.21	0.81	0.29	0.03	0.03	0.05
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-0.15	0.06	-0.18	0.71	1.41	2.46
Close Price ($)	1.68	6.58	46.90	156.00	276.00	778.00
High Price ($)	48.00	49.50	206.00	474.00	872.00	1,450.00
Low Price ($)	1.42	5.50	20.00	130.32	270.00	720.00
Market Cap ($ Cr)	2.34	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	0.03	0.01	0.01	0.01	0.01
Short term debt to equity ratio	0.01	0.03	0.01	0.01	0.00	0.00
Current Ratio	3.70	1.27	2.23	1.63	4.71	11.41
Quick Ratio	3.70	--	--	--	--	--
Interest Coverage	-360.69	-678.28	-176.54	-355.73	-323.78	-224.65

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	--	--	--	104.70	--	--
Asset Turnover	--	--	--	0.00	-0.01	0.00
Receivable days	--	--	--	382.40	--	-570.70
Inventory Days	--	--	--	--	--	--
Payable days	--	3,146.22	4,896.51	5,277.49	5,486,359.38	8,868,934.09
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.